A Randomized, Open-Label, Single Dose Study to Determine Relative Oral Bioavailability of AMG 221 Administered as a Tablet Formulation vs Oral Suspension Formulation and to Evaluate Effect of Food on Bioavailability of Tablet Formulation in Overweight and Obese Subjects

Sponsor ID

20060143

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

N/A

Product

N/A

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.